675
Participants
Start Date
March 21, 2018
Primary Completion Date
January 20, 2022
Study Completion Date
January 20, 2022
Rifampicin
10mg/kg
Isoniazid
5mg/kg
Pyrazinamide
25mg/kg
Ethambutol
15mg/kg
Linezolid
600mg
Clofazimine
200mg
Rifapentine
1200mg
Levofloxacin
1000mg
Bedaquiline
400mg once daily for 2 weeks then 200mg 3x a week
Rifampicin
35mg/kg
National Institute of TB and Respiratory Diseases, New Delhi
Universitas Padjadjaran, Bandung
Persahbahatan Hospital, Jakarta
Wahidin Sudirohusodo Hospital, Makassar
Saiful Anwar Hospital, Malang
Soetomo General Hospital, Surabaya
Perpetual Succour Hospital, Cebu
De La Salle Health Sciences Institute, Manila
Lung Center Philippines, Manila
Philippines Tuberculosis Society Incorporated (PTSI), Manila
Tropical Disease Foundation, Manila
Quezon Institute, Quezon City
National University Hospital, Singapore
King Chulalongkorn Memorial Hospital, Bangkok
Central Chest Institute of Thailand, Nonthaburi
Infectious Diseases Institute, Kampala
Joint Clinical Research Centre, Kampala
Joint Clinical Research Centre, Mbarara
National University Hospital, Singapore
OTHER
Singapore Clinical Research Institute (SCRI)
UNKNOWN
University College, London
OTHER